New Name, Brand for Clinical Financial Services
Clinical Financial Services (CFS), a specialty provider focused on the business and financial management activities for clinical trials, announces its new name and brand image. The company will now be known as CFS Clinical. The new image and name reflects the company’s rapid and continued growth and highlights its expanded service offerings.
CFS Clinical has two service areas within clinical trial business management: Contract and Regulatory Services and Global Payment Services which operate in unison to accelerate cycle times, manage compliance and risk and stimulate investigator relationships. To support these services, CFS Clinical has reinvented and revolutionized its technology platforms — CFS Startup InSite™ and CFS Payment InSite™ — both of which were unveiled at the DIA Conference.
According to Greg Seminack, President and Managing Partner of CFS Clinical, “Our new brand image captures what CFS Clinical is known for — transforming the business of clinical trials. It reinforces the fact that our ultimate goal is to empower biopharmaceutical and medical device companies worldwide to initiate and complete clinical trials quickly and efficiently, with better metrics and measurable ROI.” Mr. Seminack continues, “We are pleased to unveil our new identity and the continued investment in new service offerings that our new name conveys.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
